Hints and tips:
Related Special Reports
...Alongside Ubben, Bayer nominated Nancy Simonian, the former CEO of US biotech company Syros Pharmaceuticals, and Lori Schechter, the former general counsel of US healthcare group McKesson, to join its supervisory...
...Manns said asundexian was the most promising drug in Bayer’s pharma pipeline. “Without it, the pharma unit is left without sustainable growth.”...
...and Serbia 200th day of the Hamas-Israel conflict after Hamas launched an attack on Israel on October 7 last year UK: 100th anniversary of both the first radio broadcast by a British monarch, George V...
...They produce prescription drugs against cancer, heart disease and other illness, over-the-counter healthcare products like Bepanthen cream as well as seeds and herbicides for farmers....
...He added that Bayer was “deprioritising Europe to some degree” and focusing on the US and China, where its pharma division has already established a significant market presence....
...Meanwhile, Germany’s Bayer in January said it was cutting jobs in Britain because of the UK medicines levy....
...The UK spends a smaller proportion of its gross domestic product on healthcare than most other OECD countries, he said, and a smaller part of its healthcare budget on drugs....
...And though the huge but inefficient US healthcare market is by far the most lucrative for pharma companies, the Inflation Reduction Act introduced price negotiation on some drugs....
...A record 271 cross-border licensing partnerships were agreed in 2020 between multinational groups including Roche, Bayer, AbbVie and Pfizer and Chinese pharma companies, according to data from consultancy...
...The company is also expanding beyond its headquarters in London to a second office in Lausanne, Switzerland, home to a host of leading pharma companies including Roche, Novartis and Bayer, and Isomorphic...
...“At the same time the world’s big pharma and technology companies are coming here to make use of our genomics environment and plug into our data sets.”...
...The architect of the healthcare strategy, Frans van Houten, left Philips last month. Litigation from afflicted US patients looms....
...Accordingly, big pharma groups like Pfizer, Bayer and Regeneron have taken note, forming partnerships with the pioneers....
...The Russian Direct Investment Fund, the Kremlin’s state wealth fund that has financed the Gamaleya Institute’s Sputnik V vaccine, declined to comment on the Mexico trials but said approval by national healthcare...
...German drug and agrochemical conglomerate Bayer has also threatened to suspend crop sales to Russia next year unless it stops attacking Ukraine....
...Bayer is set to buy a Californian biopharmaceuticals start-up for up to $2bn as the German drugs and agrochemicals group pushes into novel therapeutic and research approaches in healthcare....
...the new pharma-focused GSK....
...Its three biggest rivals are also pharmaceutical companies — Johnson & Johnson, Bayer and Sanofi — but healthcare has been an area of growth for consumer goods companies such as Reckitt Benckiser and Procter...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...The company needs to produce and deliver the jab — a process that has proved fraught for most pharma groups....
...“It’s the biggest vaccine programme in history and the logistics are enormous,” said Dr Nigel Watson, chief executive of the Wessex Local Medical Committees....
...Big Pharma steps up Thomas Cueni, head of the International Federation of Pharmaceutical Manufacturers and Associations, says coronavirus is a pivotal moment for his members....
...An Irish drugmaker has put a price tag of almost $3,000 on a bottle of two-in-one painkillers that can be bought separately for $36, in another instance of gouging in the US, the world’s largest healthcare...
...Bayer’s US legal woes have distracted from weaknesses in its pharma business....
...US president Donald Trump has been touting hydroxychloroquine to treat Covid-19, while India has recommended the malaria drug to its healthcare workers....
International Edition